KANORICHEM.NS
Kanoria Chemicals & Industries Limited [KANORICHEM.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KANORICHEM.NS Stock Summary
Top 10 Correlated ETFs
KANORICHEM.NS
Top 10 Correlated Stocks
KANORICHEM.NS
In the News
KANORICHEM.NS Financial details
Company Rating
Neutral
Market Cap
5.72B
Income
-306.6M
Revenue
15.6B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
442
Optionable
No
Shortable
Yes
Earnings
24 May 2024
P/E
-24.52
Forward P/E
-
PEG
0.45
P/S
0.36
P/B
0.95
P/C
-
P/FCF
-
Quick Ratio
0.46
Current Ratio
1.14
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-7.01
EPS next Y
-
EPS next Q
-
EPS this Y
-228.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.08%
Revenue last 5Y
8.02%
Revenue Q/Q
-7.89%
EPS Q/Q
-55.71%
-
-
-
-
SMA20
7.89%
SMA50
-6.82%
SMA100
-1.6%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-8%
ROC
-
Gross Margin
29%
Oper. Margin
-
Profit Margin
-1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
100.0-157.0
52W High
-19.43%
52W Low
+26.5%
RSI
62
Rel Volume
0.68
Avg Volume
89.54K
Volume
60.91K
Perf Week
7.25%
Perf Month
1.4%
Perf Quarter
4.5%
Perf Half Y
-4.49%
-
-
-
-
Beta
0.48
-
-
Volatility
3.39%, 7.84%
Prev Close
0.48%
Price
126.5
Change
2.3%
KANORICHEM.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 245.62 | 229.82 | 250.51 | 313.32 | 361.25 | |
| Net income per share | -3.42 | -5.9 | 3.32 | 1.56 | -2.01 | |
| Operating cash flow per share | 9.48 | 7.11 | 18.87 | 19.01 | 5.89 | |
| Free cash flow per share | 1.52 | -3.68 | 12.55 | 9.2 | -7.27 | |
| Cash per share | 11.4 | 11.05 | 7.97 | 7.2 | 7.05 | |
| Book value per share | 136.98 | 130.11 | 134.4 | 136.94 | 138.56 | |
| Tangible book value per share | 130.7 | 123.95 | 127.45 | 129.08 | 129.91 | |
| Share holders equity per share | 136.98 | 130.11 | 134.4 | 136.94 | 138.56 | |
| Interest debt per share | 124.8 | 131.55 | 119.59 | 113.2 | 124.95 | |
| Market cap | 2.82B | 1.03B | 3.98B | 5.97B | 4.66B | |
| Enterprise value | 7.76B | 6.1B | 8.59B | 10.53B | 9.57B | |
| P/E ratio | -18.87 | -3.99 | 27.39 | 87.5 | -53.08 | |
| Price to sales ratio | 0.26 | 0.1 | 0.36 | 0.44 | 0.29 | |
| POCF ratio | 6.8 | 3.31 | 4.82 | 7.19 | 18.1 | |
| PFCF ratio | 42.4 | -6.39 | 7.26 | 14.85 | -14.66 | |
| P/B Ratio | 0.47 | 0.18 | 0.68 | 1 | 0.77 | |
| PTB ratio | 0.47 | 0.18 | 0.68 | 1 | 0.77 | |
| EV to sales | 0.72 | 0.61 | 0.78 | 0.77 | 0.61 | |
| Enterprise value over EBITDA | 10.96 | 13.66 | 8 | 12.19 | 11.57 | |
| EV to operating cash flow | 18.72 | 19.64 | 10.41 | 12.68 | 37.2 | |
| EV to free cash flow | 116.78 | -37.89 | 15.67 | 26.19 | -30.12 | |
| Earnings yield | -0.05 | -0.25 | 0.04 | 0.01 | -0.02 | |
| Free cash flow yield | 0.02 | -0.16 | 0.14 | 0.07 | -0.07 | |
| Debt to equity | 0.86 | 0.96 | 0.84 | 0.79 | 0.84 | |
| Debt to assets | 0.37 | 0.4 | 0.36 | 0.34 | 0.34 | |
| Net debt to EBITDA | 6.98 | 11.35 | 4.3 | 5.28 | 5.94 | |
| Current ratio | 1.11 | 1.07 | 1.22 | 1.24 | 1.12 | |
| Interest coverage | 0.45 | -0.87 | 1.21 | 0.56 | 0.38 | |
| Income quality | 3.08 | -0.72 | 5.42 | 6.33 | -2.11 | |
| Dividend Yield | 0.03 | 0.04 | 0.01 | 0 | 0.01 | |
| Payout ratio | -0.53 | -0.15 | 0.27 | 0 | -0.5 | |
| Sales general and administrative to revenue | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | |
| Capex to operating cash flow | -0.84 | -1.52 | -0.34 | -0.52 | -2.23 | |
| Capex to revenue | -0.03 | -0.05 | -0.03 | -0.03 | -0.04 | |
| Capex to depreciation | -1.73 | -0.84 | -0.48 | -0.75 | -0.98 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 102.6 | 131.45 | 100.26 | 69.38 | 79.11 | |
| ROIC | 0.02 | -0.02 | 0.05 | 0 | 0.01 | |
| Return on tangible assets | -0.01 | -0.02 | 0.01 | 0.01 | -0.01 | |
| Graham Net | -151.08 | -151.47 | -110.06 | -114.7 | -124.94 | |
| Working capital | 436.71M | 295.97M | 839.56M | 971.12M | 633.8M | |
| Tangible asset value | 5.71B | 5.42B | 5.57B | 5.64B | 5.68B | |
| Net current asset value | -3.3B | -3.59B | -3.07B | -2.95B | -3.02B | |
| Invested capital | 0.86 | 0.96 | 0.84 | 0.79 | 0.84 | |
| Average receivables | -304.76M | -177.73M | 1.07B | 2.06B | 2B | |
| Average payables | 1.38B | 1.53B | 1.57B | 1.82B | 2.2B | |
| Average inventory | 1.66B | 1.86B | 1.74B | 2.1B | 2.66B | |
| Days sales outstanding | -8.71 | -3.61 | 74.46 | 50.28 | 48.94 | |
| Days payables outstanding | 70.75 | 82.14 | 75.19 | 77.83 | 75.41 | |
| Days of inventory on hand | 91.44 | 93.39 | 81.08 | 94.23 | 90.8 | |
| Receivables turnover | -41.91 | -101.05 | 4.9 | 7.26 | 7.46 | |
| Payables turnover | 5.16 | 4.44 | 4.85 | 4.69 | 4.84 | |
| Inventory turnover | 3.99 | 3.91 | 4.5 | 3.87 | 4.02 | |
| ROE | -0.02 | -0.05 | 0.02 | 0.01 | -0.01 | |
| Capex per share | -7.96 | -10.79 | -6.33 | -9.81 | -13.16 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 88.21 | 101.81 | 91.88 | 85 | 78.29 | |
| Net income per share | -0.29 | -0.35 | -0.6 | -4.2 | -1.86 | |
| Operating cash flow per share | 6.66 | 7.07 | 7.2 | -0.72 | 7.27 | |
| Free cash flow per share | 6.66 | 7.07 | 7.2 | -8.85 | 7.27 | |
| Cash per share | 4.64 | 7.05 | 6.37 | 3.19 | 0 | |
| Book value per share | 136.22 | 138.56 | 138.93 | 140.74 | 0 | |
| Tangible book value per share | 0 | 129.91 | 0 | 137.53 | 0 | |
| Share holders equity per share | 136.22 | 138.56 | 138.93 | 140.74 | 0 | |
| Interest debt per share | 2.29 | 119.14 | 2.47 | 112.71 | 2.06 | |
| Market cap | 6.94B | 4.66B | 4.81B | 6.1B | 5.88B | |
| Enterprise value | 7.15B | 9.57B | 5.09B | 10.83B | 5.88B | |
| P/E ratio | -136.67 | -76.57 | -45.58 | -8.3 | -18.07 | |
| Price to sales ratio | 1.8 | 1.05 | 1.2 | 1.64 | 1.72 | |
| POCF ratio | 23.86 | 15.07 | 15.3 | -193.57 | 18.5 | |
| PFCF ratio | 23.86 | 15.07 | 15.3 | -15.76 | 18.5 | |
| P/B Ratio | 1.17 | 0.77 | 0.79 | 0.99 | 0 | |
| PTB ratio | 1.17 | 0.77 | 0.79 | 0.99 | 0 | |
| EV to sales | 1.85 | 2.15 | 1.27 | 2.92 | 1.72 | |
| Enterprise value over EBITDA | 35.85 | 41.54 | 19.61 | 200.27 | 209.14 | |
| EV to operating cash flow | 24.56 | 30.96 | 16.19 | -343.96 | 18.5 | |
| EV to free cash flow | 24.56 | 30.96 | 16.19 | -28 | 18.5 | |
| Earnings yield | 0 | 0 | -0.01 | -0.03 | -0.01 | |
| Free cash flow yield | 0.04 | 0.07 | 0.07 | -0.06 | 0.05 | |
| Debt to equity | 0 | 0.84 | 0 | 0.78 | 0 | |
| Debt to assets | 0 | 0.34 | 0 | 0.33 | 0 | |
| Net debt to EBITDA | 1.02 | 21.33 | 1.07 | 87.56 | 0 | |
| Current ratio | 0 | 1.12 | 0 | 1.14 | 0 | |
| Interest coverage | 0.54 | 0.72 | -0.48 | -0.85 | -1.45 | |
| Income quality | -22.91 | -20.38 | -11.92 | 0.17 | -3.91 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.03 | 0 | 0.03 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 11.28 | 0 | |
| Capex to revenue | 0 | 0 | 0 | -0.1 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | -1.15 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 29.85 | 32.93 | 43.46 | 115.39 | 0 | |
| ROIC | 0.01 | 0 | -0.01 | -0.01 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | -0.01 | 0 | |
| Graham Net | 4.64 | -124.94 | 6.37 | -119.1 | 0 | |
| Working capital | 202.9M | 633.8M | 278.5M | 671.8M | 0 | |
| Tangible asset value | 0 | 5.68B | 0 | 6.01B | 0 | |
| Net current asset value | 202.9M | -3.02B | 278.5M | -2.74B | 0 | |
| Invested capital | 0 | 0.84 | 0 | 0.78 | 0 | |
| Average receivables | 895.25M | 1.06B | 1.06B | 1.07B | 1.07B | |
| Average payables | 979.85M | 1.15B | 1.15B | 1.15B | 1.15B | |
| Average inventory | 1.42B | 1.39B | 1.39B | 1.4B | 1.4B | |
| Days sales outstanding | 0 | 42.82 | 0 | 51.93 | 0 | |
| Days payables outstanding | 0 | 65.31 | 0 | 79.98 | 0 | |
| Days of inventory on hand | 0 | 78.64 | 0 | 97.11 | 0 | |
| Receivables turnover | 0 | 2.1 | 0 | 1.73 | 0 | |
| Payables turnover | 0 | 1.38 | 0 | 1.13 | 0 | |
| Inventory turnover | 0 | 1.14 | 0 | 0.93 | 0 | |
| ROE | 0 | 0 | 0 | -0.03 | 0 | |
| Capex per share | 0 | 0 | 0 | -8.13 | 0 |
KANORICHEM.NS Frequently Asked Questions
What is Kanoria Chemicals & Industries Limited stock symbol ?
Kanoria Chemicals & Industries Limited is a IN stock and trading under the symbol KANORICHEM.NS
What is Kanoria Chemicals & Industries Limited stock quote today ?
Kanoria Chemicals & Industries Limited stock price is $126.5 today.
Is Kanoria Chemicals & Industries Limited stock public?
Yes, Kanoria Chemicals & Industries Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 89.54K
- Market Capitalization 5.72B
- Employee 442
- CEO Mr. Rajya Vardhan Kanoria B.Sc.
- Headquarters New Delhi,IN
- IPO Date 2002-07-01
-
Website
https://www.kanoriachem.com 
Kanoria Chemicals & Industries Limited manufactures and sells chemical intermediates in India. The company operates through Alco Chemicals and Solar Power segments. It provides chemicals, such as acetaldehyde, di-pentaerythritol, formaldehyde, hexamine, pentaerythritol, phenolic resins, and sodium formate. The company also develops and sells electronic and mechatronic modules, and control devices for the automotive, consumer goods, power tool electronics, and building automation industries. In addition, it operates a solar power plant with a generation capacity of 5 MW in Jodhpur district, Rajasthan; and manufactures and sells yarn and denim. The company also exports its products. The company was incorporated in 1960 and is based in New Delhi, India. Kanoria Chemicals & Industries Limited is a subsidiary of Vardhan Limited.
